Genzyme Patent Rights definition

Genzyme Patent Rights means Patent Rights claiming Inventions or Joint Inventions discovered, made or conceived during and in connection with the Program that are owned or controlled by, or licensed (with the right to sublicense) to, Genzyme, to the extent that such Patent Rights cover a compound, composition, biological or other material, product-by-process, method, apparatus, manufacturing or other process, relating to or useful in the Field.
Genzyme Patent Rights means all Patent Rights owned or controlled by, or licensed (to the extent licensed and if there is the right to sublicense) to, Genzyme, to the extent that such Patent Rights claim Collaboration Products or are necessary for the research, development, manufacture or commercialization of Collaboration Products in the Field. The Genzyme Patent Rights in existence on the Effective Date are set forth on Schedule 1.17. This schedule will be updated by Genzyme on the LLC Formation Date to include all Genzyme Patent Rights owned or controlled by Genzyme as of such date.
Genzyme Patent Rights means those Patent Rights Controlled by Genzyme during the Term that are reasonably necessary or useful to Develop, Commercialize and/or Manufacture Global AT3 Licensed Products in the Field in the Licensed Territory. Genzyme Patent Rights excludes Patent Rights included in Genzyme Collaboration IP, Genzyme’s interest in Joint Collaboration IP and Genzyme Manufacturing IP.

Examples of Genzyme Patent Rights in a sentence

  • Notwithstanding the foregoing, Genzyme Patent Rights do not include any Patent Rights Controlled by Genzyme under the Avigen Agreement except to the extent such Patent Rights are Genzyme PD Patent Rights and the DAC has elected to utilize the Genzyme PD Technology in accordance with Section 4.5 (Use of Genzyme PD Technology).

  • In doing so, Members must satisfy themselves that sufficient mechanisms are in place to ensure both that savings are delivered and that new expenditure is contained within the available resources.

  • Except as agreed in writing by Genzyme and BioMarin, the Controlling Party shall not enter into any settlement relating to a Collaboration Product, if such settlement admits the invalidity or unenforceability of any Patent Rights within the BioMarin Patent Rights or the Genzyme Patent Rights, as applicable, of the other Party.

  • To avoid duplication, a station using money from this appropriation to construct a tower must consult with public radio stations in its area to determine if they have a similar need.

  • The Party subject to such Action (for purposes of this Section 9.6, the “Controlling Party”) shall have the exclusive right to defend and control the defense of any such Action using counsel of its own choice; provided, however, that if such Action is directed to the subject of the Patent Rights of the other Party (i.e., the BioMarin Patent Rights or the Genzyme Patent Rights), such other Party may participate in the defense and/or settlement thereof at its own expense with counsel of its choice.

  • This paper examines headless object relative clauses in Late Archaic Chinese of the 5th to 3rd centuries BCE1 and proposes that they are reduced relative clauses with genitive subjects.

  • Diacrin and Genzyme shall each promptly notify the other in writing of any alleged or threatened infringement of any patents or patent applications comprising the Diacrin or Genzyme Patent Rights or if either Party, or any of their respective Affiliates, shall be individually named as a defendant in a legal proceeding by a Third Party for infringement of a patent because of the manufacture, use or sale of a Collaboration Product.

  • The foregoing provisions of this Article 9 shall ------------------ be subject to and limited by any agreements pursuant to which BioMarin and Genzyme, as the case may be, acquired any particular BioMarin Patent Rights, BioMarin Technology or Genzyme Patent Rights or Genzyme Technology.

  • Granular bedding material shall be compacted to seventy (70) percent relative density for sand materials as determined by the relative density of cohesionless soils test, ASTM D-2049.

  • Except as otherwise expressly provided herein, Genzyme hereby grants to BioMarin/Genzyme LLC a worldwide, exclusive, royalty-free right and license during the term of this Agreement under the Genzyme Patent Rights, Genzyme Technology, BioMarin/Genzyme Patent Rights and the BioMarin/Genzyme Technology and Manufacturing Know-How Controlled by Genzyme to develop, make, have made, use, offer for sale, sell, have sold, import and export Collaboration Products for use in the Field and in the Territory.


More Definitions of Genzyme Patent Rights

Genzyme Patent Rights means all present Patent Rights owned or controlled by, or licensed (with the right to sublicense where possible) to, Genzyme, to the extent that such Patent Rights cover a compound, composition, biological or other material, product-by-process, method, apparatus, manufacturing or other process, relating to or useful for the research, development, manufacture or commercialization of Collaboration Products for use in the Field, including the Genzyme Patent Rights listed in SCHEDULE 1.21 hereto.
Genzyme Patent Rights means all present Patent Rights owned or controlled by, or licensed (with the right to sublicense where possible) to Genzyme, to the extent that such Patent Rights cover a compound, composition, biological or other material, product-by process, method, apparatus, manufacturing or other process, relating to or useful for the research, development, manufacture or commercialization of Collaboration Products for use in the Field, including the Genzyme Patent Rights listed in Schedule I hereto. "GENZYME TECHNOLOGY" shall mean Technology (as defined below) owned and controlled by, or licensed (with the right to sublicense) to, Genzyme relating to or useful for the research, development, manufacture or commercialization of Collaboration Products for use in the Field. "GENZYME/GTC PATENT RIGHTS" shall mean the Patent Rights that claim Joint Inventions that have been or are jointly discovered, made or conceived during and in connection with the "Program" as defined in the Original Collaboration Agreement and the Program to the extent that such Patent Rights cover a compound, composition, biological or other material, product-by-process, method, apparatus, manufacturing or other process, or transgenic technology relating to or useful for the research, development, manufacture or commercialization of Collaboration Products for use in the Field. "GENZYME/GTC TECHNOLOGY" shall mean all Technology discovered, made or conceived during and in connection with the "Program" as defined in the Original Collaboration Agreement and hereunder, and future Technology owned or controlled by, or licensed (with the right to sublicense where possible) to either Genzyme or GTC relating to or useful for the research, development, manufacture or commercialization of Collaboration Products for use in the Field.
Genzyme Patent Rights means (a) the Patent Rights that Cover the Genzyme Know-How and that are listed on Schedule 1.2.51 and (b) any Patent Rights added to Schedule 1.2.51. Genzyme Patent Rights excludes Patent Rights included in Genzyme’s interest in Joint Collaboration IP.
Genzyme Patent Rights means those Patent Rights Controlled by Genzyme during the Term that are reasonably necessary or useful to Develop, Commercialize and/or Manufacture Regional Licensed Products in the Field in the Alnylam Territory; Genzyme Patent Rights excludes Patent Rights included in Genzyme Collaboration IP, Genzyme’s interest in Joint Collaboration IP and Genzyme Manufacturing IP. CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT WERE OMITTED AND REPLACED WITH “[***]”. A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECRETARY OF THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO AN APPLICATION REQUESTING CONFIDENTIAL TREATMENT UNDER RULE 24b-2 OF THE SECURITIES EXCHANGE ACT OF 1934. REGIONAL LICENSE TERMS
Genzyme Patent Rights means all Patent Rights Controlled by Genzyme during the Term to the extent that such Patent Rights relate to or are useful for the research, development, manufacture or commercialization of Collaboration Products for use in the Field. [**] = Portions of this exhibit have been omitted pursuant to a confidential treatment request. An unredacted version of this exhibit has been filed separately with the Commission.

Related to Genzyme Patent Rights

  • Licensed Patent Rights means:

  • Program Patent Rights means any Patent Rights that contain one or more claims that cover Program Inventions.

  • Joint Patent Rights means Patent Rights that contain one or more claims that cover Joint Technology.

  • Patent Rights means the rights and interests in and to issued patents and pending patent applications (which, for purposes of this Agreement, include certificates of invention, applications for certificates of invention and priority rights) in any country or region, including all provisional applications, substitutions, continuations, continuations-in-part, divisions, renewals, all letters patent granted thereon, and all reissues, re-examinations and extensions thereof, and all foreign counterparts of any of the foregoing.

  • Collaboration Patent Rights means Patent Rights claiming Collaboration Know-How.

  • Patent Right means: (a) an issued or granted patent, including any extension, supplemental protection certificate, registration, confirmation, reissue, reexamination, extension or renewal thereof; (b) a pending patent application, including any continuation, divisional, continuation-in-part, substitute or provisional application thereof; and (c) all counterparts or foreign equivalents of any of the foregoing issued by or filed in any country or other jurisdiction.

  • Licensed Patents means (a) all United States patents and patent applications listed in Exhibit A, as modified pursuant to Section 2.6.1, including patents arising from such patent applications; and (b) any re-examination certificates thereof, and their foreign counterparts and extensions, continuations, divisionals, and re-issue applications; provided that “Licensed Patents” will not include any claim of a patent or patent application covering any Manufacturing Technology.

  • Licensed Patent means Stanford's rights in U.S. Patent Application, Serial Number , filed , any foreign patent application corresponding thereto, and any divisional, continuation, or reexamination application, extension, and each patent that issues or reissues from any of these patent applications. Any claim of an unexpired Licensed Patent is presumed to be valid unless it has been held to be invalid by a final judgment of a court of competent jurisdiction from which no appeal can be or is taken. “Licensed Patent” excludes any continuation-in-part (CIP) patent application or patent.

  • Collaboration Patents means any and all Patents that claim or cover any of the Collaboration Know-How.

  • Licensee Patents means all Patents that (i) claim any inventions developed by or on behalf of Licensee in the Development, manufacture or Commercialization of any of the Products in the Field pursuant to this Agreement, or (ii) are Controlled by Licensee or its Affiliates during the Term and claim or cover any of the Products (including composition of matter, methods of manufacturing and methods of treatment or use).”

  • Assigned Patent Rights means all of the following, whether now owned or hereafter acquired or arising:

  • Regents' Patent Rights means REGENTS' rights in (a) the patent and patent applications expressly identified in Appendix C and their foreign counterparts;

  • Joint Patents has the meaning set forth in Section 8.1.

  • Joint Patent means a patent that issues from a Joint Patent Application.

  • Valid Patent Claim means a claim of an issued and unexpired Patent which has not been disclaimed, revoked, held unenforceable or invalid by a decision of a court or other governmental agency of competent jurisdiction, unappealable or unappealed within the time allowed for appeal, and which has not been admitted to be invalid or unenforceable through reissue or disclaimer or otherwise.

  • Product Patents means any Patent Controlled or owned by Quoin in the Territory that, absent the license in Section 2.1, would be infringed by the importation, sale, or use of the Product in the Territory by a third party.

  • Licensed IP means the Licensed Patents and the Licensed Know-How.

  • Joint IP means Joint Know-How and Joint Patents.

  • Company Patents means Patents owned by the Company or used or held for use by the Company in the Business.

  • Licensee Technology means the Licensee Know-How and Licensee Patents.

  • Product Infringement has the meaning set forth in Section 9.4(a).

  • Licensor Technology means the Licensor Patents and the Licensor Know-How.

  • Product Technology means the Product Know-How and Product Patents.

  • Collaboration IP means Collaboration Know-How and Collaboration Patents.

  • Licensed Technology means the Licensed Patents and the Licensed Know-How.

  • Program Technology means Program Know-How and Program Patents.